Zingiber zerumbet (L.) J. E. SMITH (Zingiberaceae), a wild ginger, grows widely in Southeast Asia, and its rhizomes are used traditionally to treat inflammation.
Zingiber zerumbet (L.) J. E. SMITH (Zingiberaceae), a wild ginger, grows widely in Southeast Asia, and its rhizomes are used traditionally to treat inflammation. 1) Previous phytochemical investigations on this plant resulted in the isolation of several sesquiterpenoids and flavonoids. [2] [3] [4] In particular, a monocyclic sesquiterpene, zerumbone (2E,6E,10E-humulatrien-1-one), determined to be a major component of the essential oil of Z. zerumbet, has been studied intensively as a potential anti-inflammatory and chemopreventive. 2, 5, 6) In our ongoing project directed toward the discovery of novel naturally occurring inducible nitric oxide synthase (iNOS) inhibitory agents in higher plants, 7) the rhizomes of Z. zerumbet were chosen for detailed investigation, since the nhexane-soluble fraction of its MeOH extract was found to significantly inhibit (IC 50 ϭ2.74 mg/ml) lipopolysaccharide (LPS)-induced nitric oxide (NO) production in murine macrophage RAW 264.7 cells. NO is a short-lived molecule that is required for many physiological functions, and is produced from L-arginine by NO synthase (NOS). 8) Moreover, overproduced NO can stimulate tumor growth and metastasis by promoting the migratory, invasive, and angiogenic potentials of tumor cells. 9) Thus, inhibitors or suppressors of iNOS have potential use as therapeutic agents in certain cancers. In the present study, an in vitro iNOS inhibition assay-guided fractionation of the n-hexane-soluble fraction of the rhizomes of Z. zerumbet, led to the isolations of a new (1) and a known (2) humulene derivative. Compound 2 was identified as zerumboneoxide, a compound previously isolated from Z. zerumbet. 10, 11) However, the iNOS inhibitory activity of zerumboneoxide (2) has not been previously reported. Herein, we describe the structural elucidation of 1 and the results of biological evaluations.
Compound 1 was obtained as a colorless oil and produced a molecular ion [M] ϩ at m/z 234.1603 by HR-EI-MS, which is consistent with an elemental formula C 15 A new humulene sesquiterpene, 5-hydroxyzerumbone (5-hydroxy-2E,6E,9E-humulatrien-8-one) (1) and a known compound, zerumboneoxide (2) lated structurally to zerumbone (3), which was also isolated during the present investigation; however, 1 was found to contain a hydroxyl group at C-5. The 2E,6E configuration of compound 1 was suggested by its 13 Table 1 ). The iNOS inhibitory activity of zerumboneoxide (2) has not been previously reported. Indeed, zerumbone (3), which is a known iNOS inhibitory sesquiterpene also from Z. zerumbet, 14) was found in the present study to be the principle iNOS inhibitory component, with an IC 50 value of 5.4 mM. Further investigations are needed to determine the structure-activity relationships of humulene derivatives and their mechanism of action against LPS-induced NO production.
Experimental
General Experimental Procedures Melting points were measured on a J-923 melting point apparatus (Jisico, Korea) and are quoted uncorrected. Optical rotations were obtained using a DIP-1000 digital polarimeter (Jasco, Japan) at 25°C. UV and IR spectra were recorded using a U-3000 spectrophotometer (Hitachi, Japan) and a FTS 135 FT-IR spectrometer (Bio-Rad, CA, U.S.A.), respectively. LR and HREIMS were recorded on an Autospec M393 mass spectrometer (Micromass, U.K.) operated at 70 eV. NMR experiments were conducted on a Unity INOVA 400 MHz FT-NMR (Varian, CA, U.S.A.), using TMS as an internal standard. TLC analysis was performed on Extraction and Isolation Dried and milled plant material (5 kg) was extracted with 10 l of MeOH three times by maceration. Extracts were combined and concentrated in vacuo at 40°C, and concentrated extract was suspended in H 2 O (2 l) and partitioned with 2 l of n-hexane three times to afford a n-hexane-soluble syrup on drying. This n-hexane-soluble extract (165 g) was then column chromatographed through silica gel (12ϫ42 cm, 230-400 mesh) using a combinatorial solvent system [cyclohexane (20 l), cyclohexane-CH 2 
Measurements of NO Production by LPS-Stimulated Macrophage
Cells NO formation by iNOS was followed in cultured RAW 264.7 macrophages. 7) Cells were maintained in Dulbecco's Modified Eagle Medium (DMEM) supplemented with penicillin-streptomycin and 10% fetal bovine serum (FBS) at 37°C, in 5% CO 2 humidified air. To determine the inhibitory effects of test materials on LPS-induced NO production, cells in 10% FBS-DMEM (without phenol red) were plated in 24-well plates (5ϫ10 5 cells/ml), incubated for 24 h, washed with PBS, placed in fresh medium, and then incubated in medium containing 1 mg/ml of LPS in the presence or absence of test samples. After an additional incubation for 20 h, media were collected and analyzed for nitrite (an indicator of NO production) using the Griess reaction. Absorbance was measured at 540 nm using a microplate reader, and nitrite concentrations were determined by comparison with a standard sodium nitrite curve. Percentage inhibition was expressed as [1-(NO level of test samples/NO level of vehicle-treated control)]ϫ100. IC 50 values, defined as the sample concentrations resulting in a 50% inhibition of NO production, were determined by non-linear regression analysis of percent inhibition versus concentration. N w -monomethyl-L-arginine (L-NMMA) was used as a positive control. 70.0 21.3 a) IC 50 value represents the molar concentration (mM) that inhibited iNOS activity by 50% relative to the negative control. b) N w -monomethyl-L-arginine (L-NMMA) was used as a positive control.
